IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vhcp Management, LLC

Q4 2014 Holdings

Filed 2015-02-13 | 26 holdings | $25.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BioCryst Pharmaceuticals Inc(BCRX)COM09058V103$21.2M1,744,35682.3%
Coherus Biosciences Inc(CHRS)COM19249H103$4.2M870,26916.4%
Juno Therapeutics IncCOM48205A109$74.3K1,749,9990.3%
Avalanche Biotechnologies IncCOM05337G107$73.1K1,382,7350.3%
Anacor Pharmaceuticals IncCOM032420101$38.0K1,178,4740.1%
DBV TechnologiesCOMF2927N109$34.5K693,8100.1%
GW PharmaceuticalsCOM36197T103$21.1K311,8530.1%
Zafgen IncCOM98885E103$16.7K541,4800.1%
Dyax CorpCOM26746E103$14.1K1,000,6590.1%
Heron Therapeutics Inc(HRTX)COM427746102$11.0K1,095,7340.0%
Radius Health IncCOM750469108$9.1K233,2940.0%
Flamel Technologies S.A.COM338488109$8.6K500,0000.0%
Stemline Therapeutics IncCOM85858C107$6.1K356,4000.0%
Ocera TherapeuticsCOM67552A108$4.5K703,7300.0%
ZS Pharma IncCOM98979G105$4.2K100,0000.0%
OHR PharmaceuticalCOM67778H200$4.0K477,0000.0%
TherapeuticsMD IncCOM88338N107$3.8K846,5000.0%
Lipocine IncCOM53630X104$3.5K669,9210.0%
Cynapsus Therapeutics IncCOM23257Y701$1.5K1,536,7500.0%
Sunesis PharmaceuticalsCOM867328502$1.4K536,1890.0%